These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31154085)

  • 1. Determination of genotoxic potencies of pyrrolizidine alkaloids in HepaRG cells using the γH2AX assay.
    Louisse J; Rijkers D; Stoopen G; Holleboom WJ; Delagrange M; Molthof E; Mulder PPJ; Hoogenboom RLAP; Audebert M; Peijnenburg AACM
    Food Chem Toxicol; 2019 Sep; 131():110532. PubMed ID: 31154085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative potency of fifteen pyrrolizidine alkaloids to induce DNA damage as measured by micronucleus induction in HepaRG human liver cells.
    Allemang A; Mahony C; Lester C; Pfuhler S
    Food Chem Toxicol; 2018 Nov; 121():72-81. PubMed ID: 30125636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vitro genotoxicity potency of mixtures of pyrrolizidine alkaloids can be explained by dose addition of the individual mixture components.
    Allemang A; Mahony C; Pfuhler S
    Environ Mol Mutagen; 2022 Dec; 63(8-9):400-407. PubMed ID: 36258291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-dependent genotoxic potencies of selected pyrrolizidine alkaloids in metabolically competent HepG2 cells.
    Rutz L; Gao L; Küpper JH; Schrenk D
    Arch Toxicol; 2020 Dec; 94(12):4159-4172. PubMed ID: 32910235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of in vivo genotoxicity of lasiocarpine and riddelliine in rat liver using a combined in vitro-physiologically based kinetic modelling-facilitated reverse dosimetry approach.
    Chen L; Peijnenburg A; de Haan L; Rietjens IMCM
    Arch Toxicol; 2019 Aug; 93(8):2385-2395. PubMed ID: 31289892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure/activity relationships of the genotoxic potencies of sixteen pyrrolizidine alkaloids assayed for the induction of somatic mutation and recombination in wing cells of Drosophila melanogaster.
    Frei H; Lüthy J; Brauchli J; Zweifel U; Würgler FE; Schlatter C
    Chem Biol Interact; 1992 Jun; 83(1):1-22. PubMed ID: 1643665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interim relative potency factors for the toxicological risk assessment of pyrrolizidine alkaloids in food and herbal medicines.
    Merz KH; Schrenk D
    Toxicol Lett; 2016 Nov; 263():44-57. PubMed ID: 27157086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrinsic relative potency of a series of pyrrolizidine alkaloids characterized by rate and extent of metabolism.
    Lester C; Troutman J; Obringer C; Wehmeyer K; Stoffolano P; Karb M; Xu Y; Roe A; Carr G; Blackburn K; Mahony C
    Food Chem Toxicol; 2019 Sep; 131():110523. PubMed ID: 31129256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editor's Highlight: Identification of Any Structure-Specific Hepatotoxic Potential of Different Pyrrolizidine Alkaloids Using Random Forests and Artificial Neural Networks.
    Schöning V; Hammann F; Peinl M; Drewe J
    Toxicol Sci; 2017 Dec; 160(2):361-370. PubMed ID: 28973379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Riddelliine N-oxide is a phytochemical and mammalian metabolite with genotoxic activity that is comparable to the parent pyrrolizidine alkaloid riddelliine.
    Chou MW; Wang YP; Yan J; Yang YC; Beger RD; Williams LD; Doerge DR; Fu PP
    Toxicol Lett; 2003 Dec; 145(3):239-47. PubMed ID: 14580895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potency ranking of pyrrolizidine alkaloids in metabolically competent human liver cancer cells and primary human hepatocytes using a genotoxicity test battery.
    Haas M; Wirachowski K; Thibol L; Küpper JH; Schrenk D; Fahrer J
    Arch Toxicol; 2023 May; 97(5):1413-1428. PubMed ID: 36928417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk assessment of pyrrolizidine alkaloids in food of plant and animal origin.
    Dusemund B; Nowak N; Sommerfeld C; Lindtner O; Schäfer B; Lampen A
    Food Chem Toxicol; 2018 May; 115():63-72. PubMed ID: 29524571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk assessment for pyrrolizidine alkaloids detected in (herbal) teas and plant food supplements.
    Chen L; Mulder PPJ; Louisse J; Peijnenburg A; Wesseling S; Rietjens IMCM
    Regul Toxicol Pharmacol; 2017 Jun; 86():292-302. PubMed ID: 28347763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotoxicity of selected pyrrolizidine alkaloids in human hepatoma cell lines HepG2 and Huh6.
    Hadi NSA; Bankoglu EE; Schott L; Leopoldsberger E; Ramge V; Kelber O; Sievers H; Stopper H
    Mutat Res Genet Toxicol Environ Mutagen; 2021; 861-862():503305. PubMed ID: 33551105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrrolizidine Alkaloids Induce Cell Death in Human HepaRG Cells in a Structure-Dependent Manner.
    Glück J; Waizenegger J; Braeuning A; Hessel-Pras S
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33379168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chemical structure impairs the intensity of genotoxic effects promoted by 1,2-unsaturated pyrrolizidine alkaloids in vitro.
    Buchmueller J; Enge AM; Peters A; Ebmeyer J; Küpper JH; Schäfer B; Braeuning A; Hessel-Pras S
    Food Chem Toxicol; 2022 Jun; 164():113049. PubMed ID: 35500694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic activation of pyrrolizidine alkaloids: insights into the structural and enzymatic basis.
    Ruan J; Yang M; Fu P; Ye Y; Lin G
    Chem Res Toxicol; 2014 Jun; 27(6):1030-9. PubMed ID: 24836403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism-mediated cytotoxicity and genotoxicity of pyrrolizidine alkaloids.
    He Y; Zhu L; Ma J; Lin G
    Arch Toxicol; 2021 Jun; 95(6):1917-1942. PubMed ID: 34003343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active Transport of Hepatotoxic Pyrrolizidine Alkaloids in HepaRG Cells.
    Enge AM; Kaltner F; Gottschalk C; Braeuning A; Hessel-Pras S
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption difference between hepatotoxic pyrrolizidine alkaloids and their N-oxides - Mechanism and its potential toxic impact.
    Yang M; Ma J; Ruan J; Zhang C; Ye Y; Pi-Cheng Fu P; Lin G
    J Ethnopharmacol; 2020 Mar; 249():112421. PubMed ID: 31759111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.